Company: IMRX
Filing Date: 2025-04-21
Form Type: DEF 14A
Source: 0001790340-25-000053
Chunk: 10

Company: Immuneering Corp
Filing Date: 2025-04-21
Form: DEF 14A
Chunk 10
---
 are held in street name, please contact the telephone number provided on your voting instruction form or contact your bank, broker or other nominee directly.

<div align='center'>8</div>

TABLE OF CONTENTS

#### PROPOSAL 1: ELECTION OF DIRECTORS

#### Board Size and Structure
Our Certificate of Incorporation as currently in effect (“Certificate of Incorporation”) provides that the number of directors shall be established from time to time by our Board of Directors. Our Board has fixed the number of directors at seven, and we currently have seven directors serving on the Board.

Our Certificate of Incorporation provides that the Board of Directors be divided into three classes, designated as Class I, Class II and Class III. Each class of directors must stand for re-election no later than the third annual meeting of stockholders subsequent to their initial appointment or election to the Board of Directors, provided that the term of each director will continue until the election and qualification of his or her successor and is subject to his or her earlier death, resignation or removal. Generally, vacancies or newly created directorships on the Board of Directors will be filled only by an affirmative vote of the majority of the directors then in office and will not be filled by the stockholders, unless the Board determines by resolution that any such vacancy or newly created directorship will be filled by the stockholders. A director appointed by the Board of Directors to fill a vacancy will hold office until the next election of the class for which such director was chosen, subject to the election and qualification of his or her successor and his or her earlier death, resignation or removal.

#### Current Directors and Terms
Our current directors and their respective classes and terms are set forth below.

| Class I Director -      
 Current Term Ending at  
 2025 Annual Meeting     |     | Class II Director -    
 Current Term Ending at 
 2026 Annual Meeting    |     | Class III Director -       
 Current Term Ending at     
 2027 Annual Meeting        |
| Ann E. Berman           |     | Peter Feinberg         |     | Robert J. Carpenter        |
| Diana F. Hausman, M.D.  |     | Laurie B. Keating      |     | Benjamin J. Zeskind, Ph.D. |
| Thomas J. Schall, Ph.D. |     |                        |     |                            |

#### Nominees for Director
Ms. Berman, Dr. Hausman and Dr. Schall have been nominated by the Board of Directors to stand for election. As